Crossvault Capital Management LLC Bristol Myers Squibb CO Transaction History

Crossvault Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 24, 2019	SELL	$45.12 - $53.8 $5.4 Million - $6.43 Million	-119,591 Closed	0 $0
Q4 2018 Jan 30, 2019	SELL	$48.76 - $63.23 $48,808 - $63,293	-1,001 Reduced 0.83%	119,591 $6.22 Million
Q3 2018 Oct 24, 2018	SELL	$55.19 - $62.25 $360,335 - $406,430	-6,529 Reduced 5.14%	120,592 $7.49 Million
Q2 2018 Aug 01, 2018	SELL	$50.53 - $62.98 $78,321 - $97,619	-1,550 Reduced 1.2%	127,121 $7.04 Million
Q1 2018 Apr 25, 2018	BUY	$59.92 - $68.98 $20,972 - $24,143	350 Added 0.27%	128,671 $8.14 Million
Q4 2017 Jan 23, 2018	SELL	$59.94 - $65.35 $13,486 - $14,703	-225 Reduced 0.18%	128,321 $7.86 Million
Q3 2017 Oct 30, 2017	BUY	$55.23 - $63.74 $7.1 Million - $8.19 Million	128,546	128,546 $8.19 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Crossvault Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Crossvault Capital Management LLC with notifications on news.